Rapid Micro Biosystems Files 8-K on Shareholder Votes & Financials
Ticker: RPID · Form: 8-K · Filed: May 24, 2024 · CIK: 1380106
| Field | Detail |
|---|---|
| Company | Rapid Micro Biosystems, Inc. (RPID) |
| Form Type | 8-K |
| Filed Date | May 24, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, financial-reporting, shareholder-vote
Related Tickers: RMBS
TL;DR
RMBS filed an 8-K covering shareholder votes and financials. Keep an eye on governance updates.
AI Summary
Rapid Micro Biosystems, Inc. filed an 8-K on May 23, 2024, reporting on matters submitted to a vote of security holders and financial statements. The filing details changes to the company's charter and bylaws, as well as the submission of financial information for review.
Why It Matters
This filing provides transparency to investors regarding key corporate actions and financial reporting, impacting their understanding of the company's governance and financial health.
Risk Assessment
Risk Level: low — This is a routine filing reporting on corporate actions and financial statements, not indicating any immediate operational or financial distress.
Key Players & Entities
- RAPID MICRO BIOSYSTEMS, INC. (company) — Registrant
- May 23, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 1001 Pawtucket Boulevard West, Suite 280, Lowell, MA 01854 (address) — Principal executive offices
- 978-349-3200 (phone_number) — Registrant's telephone number
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not elaborated upon in the provided text.
What is the significance of the 'Amendments to Articles of Incorporation or Bylaws' item?
This item signifies that the company has made changes to its foundational governing documents, which could impact its corporate structure or operational rules.
What type of financial statements are being reported?
The filing lists 'Financial Statements and Exhibits' as an item, suggesting that financial information is being provided, though the specific nature (e.g., quarterly, annual) is not detailed in this excerpt.
When was the company incorporated?
The company was incorporated in Delaware.
What is the primary business of Rapid Micro Biosystems, Inc.?
Rapid Micro Biosystems, Inc. operates in the 'LABORATORY ANALYTICAL INSTRUMENTS' sector, SIC code 3826.
Filing Stats: 754 words · 3 min read · ~3 pages · Grade level 10.4 · Accepted 2024-05-24 17:24:44
Key Financial Figures
- $0.01 — which registered Class A Common Stock, $0.01 par value per share RPID The Nasdaq Glo
Filing Documents
- rpid-20240523.htm (8-K) — 42KB
- ex31_rpidxamendmenttochart.htm (EX-3.1) — 8KB
- 0001380106-24-000132.txt ( ) — 187KB
- rpid-20240523.xsd (EX-101.SCH) — 2KB
- rpid-20240523_lab.xml (EX-101.LAB) — 24KB
- rpid-20240523_pre.xml (EX-101.PRE) — 14KB
- rpid-20240523_htm.xml (XML) — 3KB
03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On May 23, 2024, Rapid Micro Biosystems, Inc. (the "Company") filed with the Secretary of State of the State of Delaware a Certificate of Amendment to the Company's Restated Certificate of Incorporation, which became effective on such date. A copy of the Certificate of Amendment is included as Exhibit 3.1 and is incorporated herein by reference.
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. The Company held its annual meeting of stockholders on May 23, 2024 (the "Annual Meeting"), at which a quorum was present. There were three items of business acted upon by the stockholders. There were 37,483,559 shares of the Company's Class A common stock eligible to vote, and 35,030,255 shares were present in person or by proxy at the Annual Meeting. The following is a summary of the matters voted on at the Annual Meeting: 1. The Company's stockholders elected Kirk D. Malloy, Ph.D., Melinda Litherland and Robert Spignesi as Class III Directors to serve until the 2027 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified or until such director's earlier death, resignation or removal. The results of the stockholders' vote with respect to the election of such Class III Directors were as follows: Votes For Votes Withheld Broker Non-Votes Kirk D. Malloy, Ph.D. 26,146,777 634,808 8,248,670 Melinda Litherland 25,722,232 1,059,353 8,248,670 Robert Spignesi 25,714,563 1,067,022 8,248,670 2. The Company's stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. The results of the stockholders' vote with respect to such ratification were as follows: Votes For Votes Against Votes Abstaining Broker Non-Votes 34,230,103 790,903 9,249 0 3. The Company's stockholders approved a Certificate of Amendment to the Company's Restated Certificate of Incorporation to reflect new Delaware law provisions allowing for officer exculpation. The results of the stockholders' vote with respect to such approval were as follows: Votes For Votes Against Votes Abstaining Broker Non-Votes 26,096,227 673,920 11,438 8,248,670 No other matters were submitted to or voted on by the Company's stockholders at the Annual Meeting.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 3.1 Certificate of Amendment to Restated Certificate of Incorporation. 104 Cover Page Interactive Data File (formatted as inline XBRL).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. RAPID MICRO BIOSYSTEMS, INC. Date: May 24, 2024 By: /s/ Sean Wirtjes Sean Wirtjes Chief Financial Officer